Portola Pharma (PTLA) Reports Q3 Loss of $1.64/Share

Portola Pharma (NASDAQ: PTLA) reported Q3 EPS of ($1.64), may not compare to the analyst estimate of ($1.10).

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• Bank of America (BAC) Tops Q1 EPS by $0.07, Beats on Revenue
• Pacific Bio (PACB) says prelim. revenue for Q1 was below expectations due to customers delaying instrument purchases
• Commerce Bancshares (CBSH) Tops Q1 EPS by 5c